What This News Might Mean for Amgen | The Motley Fool
The company finds some protection against measures aimed to cut industry drug prices.
Source: fool.com
Page 2 - Astrazeneca Soliris News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Astrazeneca Soliris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Astrazeneca Soliris Today - Breaking & Trending Today
AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion
AstraZeneca (NASDAQ:AZN) announced an agreement to buy Alexion Pharmaceuticals (NASDAQ:ALXN) and its line of treatments for rare diseases for $39 billion in a combination of cash and stock. Based on AstraZeneca's closing price on Friday, Alexion shareholders are in line to receive about $175 per share. Regulatory hurdles that come with big international mergers are expected to keep this one from completing until the third quarter of 2021. Based on yesterday's closing prices for both stocks, though, AstraZeneca's offer represents a 45% premium. Image source: Getty Images. If regulators don...
Source: fool.com